TL 385 TL 385 (Terazosin Hydrochloride 5 mg)
Pill with imprint TL 385 TL 385 is Orange, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Cadista.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TL 385 TL 385
Terazosin Hydrochloride
- Imprint
- TL 385 TL 385
- Strength
- 5 mg
- Color
- Orange
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadista
- Inactive Ingredients
-
gelatin,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
corn starch,
silicon dioxide,
D&C Yellow No. 10,
D&C Red No. 28,
FD&C Red No. 40
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59746-0385 | Jubilant Cadista Pharmaceuticals Inc. |
| 67544-0563 | Prepak Systems Inc. (repackager) |
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: antiadrenergic agents, peripherally acting
- FDA Alerts (1)
Consumer resources
- Other brands
- Hytrin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.